| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 209.131 | 281.279 | 299.087 | 199.736 | 514.513 | 414.935 | 750.192 | 245.299 | 429.620 | 1.006.811 |
| Total Income - EUR | 209.582 | 281.989 | 303.282 | 199.738 | 526.442 | 425.616 | 750.561 | 245.444 | 435.153 | 1.007.456 |
| Total Expenses - EUR | 153.383 | 220.115 | 191.334 | 171.065 | 358.319 | 367.033 | 500.067 | 246.455 | 255.611 | 747.924 |
| Gross Profit/Loss - EUR | 56.199 | 61.874 | 111.947 | 28.673 | 168.123 | 58.583 | 250.494 | -1.011 | 179.542 | 259.532 |
| Net Profit/Loss - EUR | 47.133 | 52.497 | 108.386 | 26.861 | 163.067 | 54.583 | 242.988 | -3.466 | 175.676 | 212.680 |
| Employees | 10 | 11 | 13 | 12 | 12 | 14 | 14 | 11 | 12 | 12 |
Check the financial reports for the company - Agameds Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 46.337 | 32.811 | 17.113 | 8.260 | 5.937 | 10.709 | 6.883 | 8.493 | 15.813 | 151.961 |
| Current Assets | 152.874 | 190.181 | 219.216 | 267.415 | 331.600 | 276.638 | 538.240 | 229.824 | 298.759 | 375.565 |
| Inventories | 0 | 9.847 | 12.464 | 6.400 | 7.423 | 32.920 | 27.042 | 37.588 | 43.503 | 47.228 |
| Receivables | 144.828 | 180.267 | 206.030 | 177.358 | 206.124 | 145.265 | 192.403 | 108.103 | 143.331 | 231.432 |
| Cash | 8.045 | 67 | 722 | 83.657 | 118.053 | 98.454 | 318.795 | 84.133 | 111.925 | 96.905 |
| Shareholders Funds | 143.095 | 52.586 | 160.082 | 184.005 | 276.075 | 208.990 | 447.344 | 39.710 | 215.265 | 230.078 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 56.579 | 170.865 | 76.699 | 92.113 | 61.896 | 78.783 | 98.196 | 199.025 | 99.723 | 297.863 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Agameds Srl